English

3-nitro-4-((tetrahydro-2H-pyran-4-yl)methylamino)benzenesulfonamide CAS No.:1235865-75-4

December 2, 2025

3-nitro-4-((tetrahydro-2H-pyran-4-yl)methylamino)benzenesulfonamide is key intermediate of ABT 199, which is now have been mass produced.  

Basic Information

【Product name】 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide
【 Molecular Weight 】 315.35
【CAS】[1235865-75-4 ]
【Physical Properties】White to off-white solid powder, Assay≥97%,total impurities≤2.5%

Product Manager: Grace Zhang/grace@coreychem.com

 

Q1: What is ABT-199 (Venetoclax)?

A1: ABT-199 (Venetoclax) is an experimental B-cell lymphoma 2 (BCL-2) inhibitor jointly developed by AbbVie and Roche.
 

Q2: What is the function of ABT199?

A2: It is a small-molecule inhibitor targeting the BCL-2 protein, widely applied in the treatment of hematologic malignancies such as chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). ABT-199 selectively inhibits the BCL-2 protein, blocking its anti-apoptotic function and thereby inducing programmed cell death in cancer cells.
 

Q3: What is the mechanism of action of ABT-199?

A3: ABT-199 is designed to selectively inhibit the function of the BCL-2 protein, restore the cell’s communication system, and induce cancer cells to self-destruct, thereby achieving the effect of treating tumors.
 

Q4: What is the chemical name of the ABT-199 intermediate?

A4: The chemical name of the ABT-199 intermediate is 3-nitro-4-[(tetrahydro-2H-pyran-4-yl)methylamino]benzenesulfonamide.
 

Q5: What is the role of the ABT-199 intermediate in the synthesis of ABT-199?

A5: It is a key intermediate for the synthesis of ABT-199. This intermediate provides the core skeleton within the drug’s molecular structure, ensuring the high efficiency and targeting specificity of the final product.
 

Q6: What are the uses of the ABT-199 intermediate?

A6: The ABT-199 intermediate (3-nitro-4-[(tetrahydro-2H-pyran-4-yl)methylamino]benzenesulfonamide) is a reagent used in the synthesis of BTK, PI3K, and JAK-2 inhibitors, and also serves as a pharmaceutical intermediate. The high purity and stability of this intermediate are crucial for the synthesis pathway of ABT-199. Its quality directly affects the activity, safety, and pharmacokinetic properties of the final drug, and therefore it must strictly comply with pharmaceutical-grade standards.

Other intermediates for ABT199:

CAS: 1228780-72-0     1-((4′-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazine

CAS: 1228779-96-1     3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide

CAS: 1228837-05-5    4′-chloro-5,5-dimethyl-3,4,5 ,6-tetrahydro-[1,1′-biphenyl]- 2-carbaldehyde

CAS: 183208-36-8      5-methoxy-1H-pyrrolo[2,3-b]x pyridine

CAS:  1235865-76-5    methyl 2-((1H-pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4′-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1′-biphenyl]-2-yl)methyl)piperazin-1-yl)benzoate  

CAS: 98549-88-3    1H-pyrrolo[2,3-b]pyridin-5-ol

For any questions or more details, feel free to contact me at grace@coreychem.com

 

 

 

You can also fill out our online message form and we will contact you within 24 hours.